CHARACTERIZATION OF TRANSGENIC PIGS EXPRESSING AN ANTI-CD2 MONOCLONAL ANTIBODY. A CONTINUING QUEST FOR THE IDEAL ISLET DONOR

被引：0
|
作者：
Salvaris, Evelyn [1 ]
Thomas, Adwin [2 ]
Byrne, Nicole [2 ]
Fisicaro, Nella [1 ]
Nottle, Mark B. [3 ]
Hawthorne, Wayne J. [2 ,4 ]
Cowan, Peter J. [1 ,5 ]
机构：
[1] St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic, Australia
[2] Westmead Inst Med Res, Ctr Transplant & Renal Res, Westmead, NSW, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
XENOTRANSPLANTATION | 2021年 / 28卷 / 05期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
130.8
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
    Tada, Minoru
    Tatematsu, Ken-ichiro
    Ishii-Watabe, Akiko
    Harazono, Akira
    Takakura, Daisuke
    Hashii, Noritaka
    Sezutsu, Hideki
    Kawasaki, Nana
    MABS, 2015, 7 (06) : 1138 - 1150
  • [22] ANTI-CD2 MONOCLONAL-ANTIBODY SUPPRESSES THE GENERATION OF CYTOTOXIC T-LYMPHOCYTE INVIVO AND INVITRO
    BROMBERG, JS
    QIN, L
    LIN, J
    CHAVIN, KD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A279 - A279
  • [23] ANTI-CD2 MONOCLONAL ANTIBODY-INDUCED RECEPTOR CHANGES - DOWN-MODULATION OF CELL-SURFACE CD2
    LIN, JX
    YON, RW
    CHAVIN, KD
    QIN, LH
    WOODWARD, J
    DING, YZ
    YAGITA, H
    BROMBERG, JS
    TRANSPLANTATION, 1995, 59 (08) : 1162 - 1171
  • [24] Essential roles of V α 14 NKT cells for acceptance of rat islet xenografts in mice treated with anti-CD4 monoclonal antibody.
    Yasunami, Y
    Ikehara, Y
    Kodama, S
    Nakano, M
    Maki, T
    Nakayama, T
    Taniguchi, M
    Ikeda, S
    TRANSPLANTATION, 2000, 69 (08) : S145 - S145
  • [25] Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34
    Hoffmann, JC
    Herklotz, C
    Zeidler, H
    Bayer, B
    Rosenthal, H
    Westermann, J
    ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (12) : 716 - 722
  • [26] Population Pharmacokinetics of Siplizumab (MEDI-507), a Humanized Anti-CD2 Monoclonal Antibody, in Cancer Patients.
    Chen, Chunlin
    Janik, John E.
    Kaucic, Karen
    Roskos, Lorin
    Jallal, Bahija
    Robbie, Gabriel J.
    BLOOD, 2009, 114 (22) : 1046 - 1046
  • [27] COMBINED ANTI-CD2 AND ANTI-CD3 RECEPTOR MONOCLONAL-ANTIBODIES INDUCE DONOR-SPECIFIC TOLERANCE IN A CARDIAC TRANSPLANT MODEL
    CHAVIN, KD
    QIN, LH
    LIN, JX
    YAGITA, H
    BROMBERG, JS
    JOURNAL OF IMMUNOLOGY, 1993, 151 (12): : 7249 - 7259
  • [28] Costimulatory signal blockade by anti-CD2 monoclonal antibody in combination with 15-deoxyspergualin prolongs concordant xenograft survival
    Haga, M
    Hirahara, H
    Tsuchida, M
    Watanabe, T
    Takekubo, M
    Hayashi, J
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) : 1006 - 1008
  • [29] ANTI-CD4 AND ANTI-CD2 MONOCLONAL-ANTIBODY INFUSIONS IN SUBJECTS WITH MULTIPLE-SCLEROSIS - IMMUNOSUPPRESSIVE EFFECTS AND HUMAN ANTI-MOUSE RESPONSES
    HAFLER, DA
    RITZ, J
    SCHLOSSMAN, SF
    WEINER, HL
    JOURNAL OF IMMUNOLOGY, 1988, 141 (01): : 131 - 138
  • [30] Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody
    Gordon, EJ
    Markees, TG
    Phillips, NE
    Noelle, RJ
    Shultz, LD
    Mordes, JP
    Rossini, AA
    Greiner, DL
    DIABETES, 1998, 47 (08) : 1199 - 1206
12345